Cargando…
IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells
Doxorubicin (Dox) is the standard treatment approach for osteosarcoma (OS), while acquired drug resistance seriously attenuates its treatment efficiency. The present study aimed to investigate the potential roles of metabolic reprogramming and the related regulatory mechanism in Dox-resistant OS cel...
Autores principales: | He, Qing, Hao, Peng, He, Gang, Mai, Hantao, Liu, Wenzhou, Zhang, Weiqiong, Zhang, Kelin, Zhong, Guifang, Guo, Ruilian, Yu, Changzhi, Li, Yang, Wong, Chipiu, Chen, Qian, Chen, Yantao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344706/ https://www.ncbi.nlm.nih.gov/pubmed/35918761 http://dx.doi.org/10.1186/s12967-022-03549-7 |
Ejemplares similares
-
Oestrogen‐related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1
por: Chen, Yantao, et al.
Publicado: (2019) -
Association between different MAP levels and 30-day mortality in sepsis patients: a propensity-score-matched, retrospective cohort study
por: Zhong, Xiaoxin, et al.
Publicado: (2023) -
Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3
por: Wang, Saifeng, et al.
Publicado: (2019) -
Development and validation of a novel nomogram of 1-year mortality in the elderly with hip fracture: a study of the MIMIC-III database
por: Chen, Qian, et al.
Publicado: (2023) -
Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
por: Deng, Chuangzhong, et al.
Publicado: (2020)